• Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer 

      López-Beltrán, Antonio; Cimadamore, Alessia; Blanca, Ana; Massari, Francesco; Vau, Nuno; Scarpelli, Marina; Cheng, Liang; Montironi, Rodolfo (MDPI, 2021)
      A number of immune checkpoint inhibitors (ICIs) have been approved as first-line therapy in case of cisplatin-ineligible patients or as second-line therapy for patients with metastatic urothelial carcinoma (mUC) of the ...
    • T1 bladder carcinoma with variant histology: pathological features and clinical significance 

      López-Beltrán, Antonio; Blanca, Ana; Cimadamore, Alessia; Montironi, Rodolfo; Luque, Rafael J.; Volavšek, Metka; Chen, Liang (Springer, 2022)
      The aim of the study was to stratify high-grade T1 (HGT1) bladder urothelial carcinoma into risk categories based on the presence of variant histology when compared to conventional urothelial carcinoma. The clinicopathological ...